Intercept Announces Late-Breaking Oral Presentation and Poster Presentations at The Liver Meeting

NEXT STORY
Evolus Initiates Phase II Program with “Extra Strength” Dose for Extended Duration
PREV STORY
Global Genomic Medicine Markets, 2021-2026 – Rising Inclination for Personalized Medicine Expected to Drive Robust Growth
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Novartis announces Lancet publication of pioneering study in migraine prevention showing efficacy of Aimovig® where other treatments have failed

The LIBERTY trial is the first study of a CGRP-targeted therapy in a patient ...

author_avatar
NASDAQ Market News

AnaptysBio Announces Appointment of J. Anthony Ware, M.D. to Board of Directors

SAN DIEGO, Aug. 24, 2017 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq:ANAB), a clinical-stage biotechnology ...

author_avatar
NASDAQ Market News

Clearside Biomedical Appoints Jeffrey Edwards to Board of Directors

Succeeds Retiring Director, Evgeny ZaytsevALPHARETTA, Ga., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, ...

author_avatar
NASDAQ Market News